Skip to main content

Table 3 Distribution of MammaTyper® subtypes according to distant events

From: Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy

    no distant event with distant event
N % N % N %
Luminal A-like 195 60.6 185 94.9 10 5.1
Luminal B-like (HER2 negative) 119 37.0 103 86.6 16 13.4
Luminal B-like (HER2 positive) 2 0.6 2 100 0 0
Triple negative (ductal) 4 1.2 3 75.0 1 25.0
Not defined by St Gallen (ESR1−/PGR+) 2 0.6 1 50.0 1 50.0
Total 322 100 294 91.3 28 8.7